Journal of Cardiac Failure
Volume 14, Issue 8 , Pages 676-686 , October 2008

The Usefulness of Bioelectrical Impedance Analysis in Differentiating Dyspnea Due to Decompensated Heart Failure

  • Gaspare Parrinello, MD

      Affiliations

    • Departments of Internal Medicine
    • Corresponding Author InformationReprint requests: Prof. Gaspare Parrinello, Department of Internal Medicine, Piazza delle Cliniche 2, University of Palermo, Italy.
    • ,
  • Salvatore Paterna, MD

      Affiliations

    • Emergency Care, University of Palermo
    • ,
  • Pietro Di Pasquale, MD

      Affiliations

    • Department of Cardiology, GF Ingrassia Hospital, Palermo
    • ,
  • Daniele Torres, MD

      Affiliations

    • Departments of Internal Medicine
    • ,
  • Antonio Fatta, MD

      Affiliations

    • Departments of Internal Medicine
    • ,
  • Manuela Mezzero, MD

      Affiliations

    • Departments of Internal Medicine
    • ,
  • Rosario Scaglione, MD

      Affiliations

    • Departments of Internal Medicine
    • ,
  • Giuseppe Licata, MD

      Affiliations

    • Departments of Internal Medicine

Received 27 December 2007 ,Revised 3 April 2008 ,Accepted 11 April 2008.

References 

  1. McCraig LF, Burt CW. National Hospital Ambulatory Medical Care Survey: 2001 Emergency Department summary. Report from Centers for Disease Control and Prevention. Advance Data from Vital and Health Statistics. 335. Hyattsville, MD: National Center for Health Statistics; 2003;18
  2. Bennett SJ, Huster GA, Baker SL, et al. Characterization of the precipitant of hospitalization for heart failure decompensation. Am J Crit Care. 1998;7:168–174
  3. Stevenson LW. The limited availability of physical signs for estimating hemodynamics in chronic heart failure. JAMA. 1989;261:884–888
  4. Fonseca C. Diagnosis of heart failure in primary care. Heart Fail Rev. 2006;11:95–107
  5. McCaig L, Burt C. National Hospital Ambulatory Medical Care Survey: 2002 emergency department data. ADV Data. 2004;340:1–34
  6. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;106:416–422
  7. Nagagawa O, Ogawa Y, Itoh H, et al. Rapid transcriptional activation and early mRNA turnover of BNP in cardiocyte hypertrophy: evidence for BNP as an “emergency” cardiac hormone against ventricular overload. J Clin Invest. 1995;96:1280–1287
  8. Dabbah S, Reisner SA, Aronson D, et al. Left ventricular filling hemodynamics in patients with pulmonary edema and preserved versus reduced left ventricular ejection fraction: a prospective Doppler echocardiographic study. J Am Soc Echocadiogr. 2006;19:733–743
  9. Chen HH, Schrier RW. Pathophysiology of volume overload in acute heart failure syndromes. Am J Med. 2006;119:S11–S16
  10. Cotter G, Moshkovitz Y, Milovanov O, et al. Acute heart failure: a novel approach to its pathogenesis and treatment. Eur J Heart Fail. 2002;4:227–234
  11. Kushner RF, Schoeller DA, Fjeld CR, et al. Is the impedance index (ht2/R) significant in predicting total body water?. Am J Clin Nutr. 1992;56:835–839
  12. Sergy G, Bussolotto M, Perini P, et al. Accuracy of bioelectrical impedance analysis in estimation of extracellular space in healthy subject and in fluid retention states. Ann Nutr Metab. 1994;38:158–165
  13. Piccoli A, Rossi B, Pillon L, et al. A new method for monitoring body fluid variation by bioimpedance analysis: the RXc graph. Kidney Int. 1994;46:534–539
  14. Panella C, Guglielmi FW, Mastronuzzi T, et al. Whole-body and segmental bioelectrical parameters in chronic liver disease: effect of gender and disease stages. Hepatology. 1995;21:352–358
  15. Woodrow G, Oldroyd B, Turney JH, et al. Segmental bioelectrical impedance in patient with chronic renal failure. Clin Nutr. 1996;15:275–279
  16. Paterna S, Di Pasquale P, Parrinello G, et al. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure. A double-blind study. J Am Coll Cardiol. 2005;45:1997–2003
  17. McCullough PA, Nowak RM, McCord J, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure. Analysis from breathing not properly (BNP) multinational study. Circulation. 2002;106:416–422
  18. Bioelectrical impedance analysis in body composition measurement. Proceedings of a National Institutes of Health Technology Assessment Conference. Bethesda, Maryland, December 12–14, 1994. Am J Clin Nutr. 1996;64:387S–532S
  19. Baumgartner RN, Chumlea WC, Roche AF. Estimation of body composition from bioelectric impedance of body segments. Am J Clin Nutr. 1989;50:221–226
  20. Cleland J, Dargie H. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J. 2005;26:1527–1560
  21. Stevenson LW, Perloff JK. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA. 1989;261:884–888
  22. Vasan S, Larson MG, Benjamin EJ, et al. Congestive heart failure in subjects with normal versus reduced ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol. 1999;33:1948–1955
  23. Gehlbach BK, Geppert E. The pulmonary manifestation of left heart failure. Chest. 2004;125:669–682
  24. Kono T, Suwa M, Hanada H, et al. Clinical significance of normal cardiac silhouette in dilated cardiomyopathy: evaluation based upon echocardiography and magnetic resonance imaging. Jpn Circ J. 1992;56:359–365
  25. Knudsen CW, Omland T, Clopton P, et al. Diagnostic value of B-type natriuretic peptide and chest radiographic findings in patients with acute dyspnea. Am J Med. 2004;116:363–368
  26. Jimeno Sainz A, Gil V, Merino J, Garcia M, et al. Validity of Framingham criteria as a clinical test for systolic heart failure. Rev Clin Esp. 2006;206:495–498
  27. Vitarelli A, Tiukinhoy S, Di Luzio S, et al. The role of echocardiography in the diagnosis and management of heart failure. Heart Failure Rev. 2003;8:181–189
  28. Mehra MR. Optimizing outcomes in the patients with acute decompensated heart failure. Am Heart J. 2006;151:571–579
  29. Lang CC, Prasad N, Mcalpine HM, et al. Increased plasma levels of brain natriuretic peptide in patients with isolated diastolic dysfunction. Am Heart J. 1994;127:1635–1636
  30. Piccoli A, Pillon L, Dumler F. Impedance vector distribution by sex, race, body mass index, and age in the United States: standard reference intervals as bivariate Z scores. Nutrition. 2002;18:153–167
  31. Kyle U, Bosaeus I, De Lorenzo A, et al. Bioelectrical impedance analysis—part II: utilization in clinical practice. Clin Nutrition. 2004;23:1430–1433
  32. Cowie MR, Struthers AD, Wood DA, et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet. 1997;350:1347–1351
  33. O'Neill JO, Bott-Silverman CE, McRae AT, et al. B-type natriuretic peptide levels are not a surrogate marker for invasive hemodynamics during management of patients with severe heart failure. Am Heart J. 2005;149:363–369
  34. Davis M, Espiner E, Richards G, et al. Plasma brain natriuretic peptide in assessment of acute dyspnea. Lancet. 1994;343:440–444
  35. Daniels LB, Clopton P, Bhalla V, Krishnaswamy P, Nowak RM, McCord J, et al. How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study. Am Heart J. 2006;151:999–1005
  36. Sergi G, Lupoli L, Enzi G, et al. Reliability of bioelectrical impedance methods in detecting body fluids in elderly patients with congestive heart failure. Scand J Clin Lab Invest. 2006;66:19–30
  37. Barcarse E, Kazanegra R, Chen A, et al. Combination of B-type natriuretic peptide levels and non-invasive hemodynamic parameters in diagnosing congestive heart failure in the emergency department. Congest Heart Fail. 2004;10:171–176
  38. Weiss SJ, Kulik JP, Calloway E. Bioimpedance cardiac output measurements in patients with presumed congestive heart failure. Acad Emerg Med. 1997;4:568–573
  39. Peacock WF, Summers RL, Vogel J, Emerman CE. Impact of impedance cardiography on diagnosis and therapy of emergent dyspnea: the ED-IMPACT trial. Acad Emerg Med. 2006;13:365–371
  40. Lo HY, Liao SC, Ng CJ, et al. Utility of impedance cardiography for dyspneic patients in the ED. Am J Emerg Med. 2007;25:437–441
  41. Springfield CL, Sebat F, Johnson D, et al. Utility of impedance cardiography to determine cardiac vs. noncardiac cause of dyspnea in the emergency department. Congest Heart Fail. 2004;10(Suppl 2):14–16
  42. Packer M, Abraham WT, Mehra MR, et al. Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure. Prospective Evaluation and Identification of Cardiac Decompensation by ICG Test (PREDICT) Study Investigators and Coordinators. J Am Coll Cardiol. 2006;47:2245–2252
  43. Ypenburg C, Bax JJ, van der Wall EE, et al. Intrathoracic impedance monitoring to predict decompensated heart failure. Am J Cardiol. 2007;99:554–557
  44. Yu Cheuk-Man, Wang Li, Chau Elaine, et al. Intrathoracic impedance monitoring in patients with heart failure. Circulation. 2005;112:841–848
  45. Shotan A, Dacca S, Shochat M. Fluid overload contributing to heart failure. Nephrol Dial Transplant. 2005;20(Suppl 7):24–27
  46. Cotter G, Metra M, Milo-Cotter O, et al. Fluid overload in acute heart failure—re-distribution and other mechanisms beyond fluid accumulation. Eur J Heart Fail. 2008;10:165–169

PII: S1071-9164(08)00145-0

doi: 10.1016/j.cardfail.2008.04.005

Journal of Cardiac Failure
Volume 14, Issue 8 , Pages 676-686 , October 2008

Article Tools

* Image Usage & Resolution